Hiperhomocisteinemia como factor de riesgo trombótico en pacientes con Lupus Erimatoso Sistémico y Síndrome Antifosfolipido

Onetti, Laura; Villafañe, Susana; Menso, Emilia; Drenkard, Cristina; Gamron, Susana; Barbieris, Gloria; Onetti, Carlos M.
Rev. Fac. Cienc. Méd. (Córdoba) ; 62(3): 19-23, 2005. tab
Artículo en Español | LILACS | ID: lil-440533

Documentos relacionados

  1. Risk factors for damage accrual in primary antiphospholipid syndrome: A retrospective single-center cohort study.
  2. Pediatric Presentation of Antiphospholipid Syndrome: A Review of Recent Literature With Estimation of Local Prevalence.
  3. A 75-year-old woman with primary antiphospholipid syndrome presenting with livedoid vasculopathy.
  4. Determination of four homogeneous subgroups of patients with antiphospholipid syndrome: a cluster analysis based on 509 cases.
  5. Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry.
  6. Pattern of disease expression in SLE patients with antiphospholipid antibodies: data from Indian Systemic Lupus Erythematosus Inception cohort (INSPIRE).
  7. [Kidney disease in antiphospholipid antibody syndrome].
  8. [Systemic lupus erythematosus and antiphospholipid syndrome - diagnostic and therapeutic problems].
  9. Antiphospholipid Antibodies Increase the Risk of Fetal Growth Restriction: A Systematic Meta-Analysis.
  10. Ocular involvement in primary antiphospholipid syndrome: results of an extensive ophthalmological evaluation performed in the APS-Rio cohort.